Clinical Trial Update: GSK3640254 First Time in Human (FTIH) Study in Healthy Volunteers [Phase 1]

View source ↗

Summary

Phase 1 first-in-human study of GSK3640254 in healthy volunteers has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infections
• Infection

Drugs mentioned

• GSK3640254

Snippet

Sponsor: ViiV Healthcare | Conditions: Infection, Human Immunodeficiency Virus, HIV Infections | Phase 1 | Status: COMPLETED | Results posted: 2019-10-18